1 |
Ballesteros, J. A. and Weinstein, H. (1995) [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366-428.
|
2 |
Insel, P. A., Tang, C. M., Hahntow, I. and Michel, M. C. (2007) Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. Biochim. Biophys. Acta 1768, 994-1005.
DOI
|
3 |
Isberg, V., de Graaf, C., Bortolato, A., Cherezov, V., Katritch, V., Marshall, F. H., Mordalski, S., Pin, J. P., Stevens, R. C., Vriend, G. and Gloriam, D. E. (2015) Generic GPCR residue numbers - aligning topology maps minding the gaps. Trends Pharmacol. Sci. 36, 22-31.
DOI
|
4 |
Kawasaki, T., Saka, T., Mine, S., Mizohata, E., Inoue, T., Matsumura, H. and Sato, T. (2015) The N-terminal acidic residue of the cytosolic helix 8 of an odorant receptor is responsible for different response dynamics via G-protein. FEBS Lett. 589, 1136-1142.
DOI
|
5 |
Kazius, J., Wurdinger, K., van Iterson, M., Kok, J., Back, T. and Ijzerman, A. P. (2008) GPCR NaVa database: natural variants in human G protein-coupled receptors. Hum. Mutat. 29, 39-44.
DOI
|
6 |
Kimura, M. (1968) Evolutionary rate at the molecular level. Nature 217, 624-626.
DOI
|
7 |
Kuramasu, A., Sukegawa, J., Sato, T., Sakurai, E., Watanabe, T., Yanagisawa, T. and Yanai, K. (2011) The hydrophobic amino acids in putative helix 8 in carboxy-terminus of histamine H3 receptor are involved in receptor-G-protein coupling. Cell Signal. 23, 1843-1849.
|
8 |
Lagerstrom, M. C. and Schioth, H. B. (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339-357.
DOI
|
9 |
Munk, C., Isberg, V., Mordalski, S., Harpsoe, K., Rataj, K., Hauser, A. S., Kolb, P., Bojarski, A. J., Vriend, G. and Gloriam, D. E. (2016) GPCRdb: the G protein-coupled receptor database - an introduction. Br. J. Pharmacol. 173, 2195-2207.
DOI
|
10 |
Pierce, K. L., Premont, R. T. and Lefkowitz, R. J. (2002) Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650.
|
11 |
Pin, J. P., Galvez, T. and Prezeau, L. (2003) Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol. Ther. 98, 325-354.
DOI
|
12 |
Rana, B. K., Shiina, T. and Insel, P. A. (2001) Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41, 593-624.
DOI
|
13 |
Shoichet, B. K. and Kobilka, B. K. (2012) Structure-based drug screening for G-protein-coupled receptors. Trends Pharmacol. Sci. 33, 268-272.
DOI
|
14 |
Zhang, D., Zhao, Q. and Wu, B. (2015) Structural Studies of G Protein-Coupled Receptors. Mol. Cells 38, 836-842.
DOI
|
15 |
Wahlestedt, C., Brookes, A. J. and Mottagui-Tabar, S. (2004) Lower rate of genomic variation identified in the trans-membrane domain of monoamine sub-class of Human G-Protein Coupled Receptors: the Human GPCR-DB Database. BMC Genomics 5, 91.
DOI
|
16 |
Wang, C., Wu, H., Evron, T., Vardy, E., Han, G. W., Huang, X. P., Hufeisen, S. J., Mangano, T. J., Urban, D. J., Katritch, V., Cherezov, V., Caron, M. G., Roth, B. L. and Stevens, R. C. (2014) Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat. Commun. 5, 4355.
DOI
|
17 |
Wootten, D., Simms, J., Miller, L. J., Christopoulos, A. and Sexton, P. M. (2013) Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc. Natl. Acad. Sci. U.S.A. 110, 5211-5216.
DOI
|
18 |
Zhang, X., Choi, B. G. and Kim, K. M. (2016) Roles of dopamine receptor subregions in interactions with -Arrestin2. Biomol. Ther. (Seoul) 24, 517-522.
DOI
|
19 |
Cho, D. I., Beom, S., Van Tol, H. H., Caron, M. G. and Kim, K. M. (2006) Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine and receptors. Biochem. Biophys. Res. Commun. 350, 634-640.
DOI
|
20 |
Boutet, E., Lieberherr, D., Tognolli, M., Schneider, M., Bansal, P., Bridge, A. J., Poux, S., Bougueleret, L. and Xenarios, I. (2016) Uni-ProtKB/Swiss-Prot, the manually annotated section of the UniProt KnowledgeBase: How to use the entry view. Methods Mol. Biol. 1374, 23-54.
|
21 |
Chun, K. S. and Shim, M. (2015) EP2 induces p38 phosphorylation via the activation of Src in HEK 293 cells. Biomol. Ther. (Seoul) 23, 539-548.
|
22 |
Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Jr., Bates, M. D. and Caron, M. G. (1990) Molecular cloning and expression of the gene for a human dopamine receptor. Nature 347, 72-76.
DOI
|
23 |
Drazen, J. M., Silverman, E. K. and Lee, T. H. (2000) Heterogeneity of therapeutic responses in asthma. Br. Med. Bull. 56, 1054-1070.
DOI
|
24 |
Fredriksson, R., Lagerstrom, M. C., Lundin, L. G. and Schioth, H. B. (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272.
DOI
|
25 |
Hecht, M., Bromberg, Y. and Rost, B. (2013) News from the protein mutability landscape. J. Mol. Biol. 425, 3937-3948.
DOI
|
26 |
Stoddard, N. C. and Chun, J. (2015) Promising pharmacological directions in the world of lysophosphatidic acid signaling. Biomol. Ther. (Seoul) 23, 1-11.
DOI
|
27 |
Lee, A., Rana, B. K., Schiffer, H. H., Schork, N. J., Brann, M. R., Insel, P. A. and Weiner, D. M. (2003) Distribution analysis of nonsynonymous polymorphisms within the G-protein-coupled receptor gene family. Genomics 81, 245-248.
|
28 |
Small, K. M., Seman, C. A., Castator, A., Brown, K. M. and Liggett, S. B. (2002) False positive non-synonymous polymorphisms of G-protein coupled receptor genes. FEBS Lett. 516, 253-256.
DOI
|
29 |
Small, K. M., Tanguay, D. A., Nandabalan, K., Zhan, P., Stephens, J. C. and Liggett, S. B. (2003) Gene and protein domain-specific patterns of genetic variability within the G-protein coupled receptor superfamily. Am. J. Pharmacogenomics 3, 65-71.
DOI
|
30 |
Sounier, R., Mas, C., Steyaert, J., Laeremans, T., Manglik, A., Huang, W., Kobilka, B. K., Demene, H. and Granier, S. (2015) Propagation of conformational changes during -opioid receptor activation. Nature 524, 375-378.
DOI
|
31 |
Ahn, K. H., Nishiyama, A., Mierke, D. F. and Kendall, D. A. (2010) Hydrophobic residues in helix 8 of cannabinoid receptor 1 are critical for structural and functional properties. Biochemistry 49, 502-511.
DOI
|
32 |
Zheng, M., Zhang, X., Min, C., Choi, B. G., Oh, I. J. and Kim, K. M. (2016) Functional regulation of dopamine receptor through interaction with PICK1. Biomol. Ther. (Seoul) 24, 475-481.
DOI
|
33 |
Zhu, S., Zhang, M., Davis, J. E., Wu, W. H., Surrao, K., Wang, H. and Wu, G. (2015) A single mutation in helix 8 enhances the angiotensin II type 1a receptor transport and signaling. Cell. Signal. 27, 2371-2379.
DOI
|
34 |
Tang, C. M. and Insel, P. A. (2005) Genetic variation in G-protein-coupled receptors - consequences for G-protein-coupled receptors as drug targets. Expert Opin. Ther. Targets 9, 1247-1265.
DOI
|
35 |
Thompson, M. D., Cole, D. E., Capra, V., Siminovitch, K. A., Rovati, G. E., Burnham, W. M. and Rana, B. K. (2014a) Pharmacogenetics of the G protein-coupled receptors. Methods Mol. Biol. 1175, 189-242.
|
36 |
Thompson, M. D., Hendy, G. N., Percy, M. E., Bichet, D. G. and Cole, D. E. (2014b) G protein-coupled receptor mutations and human genetic disease. Methods Mol. Biol. 1175, 153-187.
|